Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBL.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBL.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.24.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.24.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.24.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.9.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.9.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.9.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FE.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FE.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FE.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FR.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FR.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GY.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GY.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.4.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.4.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.4.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HH.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GY.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GY.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.5.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HH.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HH.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.85NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.85NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.85NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used